Nurix is passionate in its mission of pioneering the development of small molecules that modulate the ubiquitin proteasome system (UPS) for improvement of human health.
December 17, 2015
Nurix is included in Forbes' list of "The Hottest Startups of 2015."
September 16, 2015
Celgene and Nurix Announce Collaboration Targeting Protein Homeostasis for Next-Generation Therapies in Oncology, Inflammation and Immunology.